Literature DB >> 23186718

Stem cell-based treatments for spinal cord injury.

Lindsey A Wyatt1, Hans S Keirstead.   

Abstract

Cell replacement strategies hold great promise for the treatment of central nervous system injuries and degenerative diseases. The advancement of stem cell therapies has proven to be a viable therapeutic approach to limit secondary degeneration and restore neuronal circuitry at the site of injury. Cell replacement strategies confer phenotype-specific and neurotrophic benefits to the surrounding tissue; however, the mechanisms of transplant-mediated repair are unique to each transplant population. Here, we review stem cell-based therapies for spinal cord injury and disease, involving a number of stem cell derivates. We discuss the mechanisms by which each of these populations exert their affects and briefly discuss phenotype-specific cell replacement in these models.
Copyright © 2012 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 23186718     DOI: 10.1016/B978-0-444-59544-7.00012-3

Source DB:  PubMed          Journal:  Prog Brain Res        ISSN: 0079-6123            Impact factor:   2.453


  12 in total

Review 1.  Improving the therapeutic efficacy of neural progenitor cell transplantation following spinal cord injury.

Authors:  Michael A Lane; Angelo C Lepore; Itzhak Fischer
Journal:  Expert Rev Neurother       Date:  2016-12-21       Impact factor: 4.618

Review 2.  Selected suitable seed cell, scaffold and growth factor could maximize the repair effect using tissue engineering method in spinal cord injury.

Authors:  Wen-Chen Ji; Xiao-Wei Zhang; Yu-Sheng Qiu
Journal:  World J Exp Med       Date:  2016-08-20

3.  Extracellular Vesicles Derived from Epidural Fat-Mesenchymal Stem Cells Attenuate NLRP3 Inflammasome Activation and Improve Functional Recovery After Spinal Cord Injury.

Authors:  Jiang-Hu Huang; Chun-Hui Fu; Yang Xu; Xiao-Ming Yin; Yong Cao; Fei-Yue Lin
Journal:  Neurochem Res       Date:  2020-01-17       Impact factor: 3.996

4.  Direct optic nerve sheath (DONS) application of Schwann cells prolongs retinal ganglion cell survival in vivo.

Authors:  L Guo; B Davis; S Nizari; E M Normando; H Shi; J Galvao; L Turner; J Shi; M Clements; S Parrinello; M F Cordeiro
Journal:  Cell Death Dis       Date:  2014-10-16       Impact factor: 8.469

5.  Engraftment, neuroglial transdifferentiation and behavioral recovery after complete spinal cord transection in rats.

Authors:  Sabino Luzzi; Alberto Maria Crovace; Luca Lacitignola; Valerio Valentini; Edda Francioso; Giacomo Rossi; Gloria Invernici; Renato Juan Galzio; Antonio Crovace
Journal:  Surg Neurol Int       Date:  2018-01-25

6.  Neural stem cell-derived small extracellular vesicles attenuate apoptosis and neuroinflammation after traumatic spinal cord injury by activating autophagy.

Authors:  Yuluo Rong; Wei Liu; Jiaxing Wang; Jin Fan; Yongjun Luo; Linwei Li; Fanqi Kong; Jian Chen; Pengyu Tang; Weihua Cai
Journal:  Cell Death Dis       Date:  2019-04-18       Impact factor: 8.469

7.  Neural stem cell small extracellular vesicle-based delivery of 14-3-3t reduces apoptosis and neuroinflammation following traumatic spinal cord injury by enhancing autophagy by targeting Beclin-1.

Authors:  Yuluo Rong; Wei Liu; Chengtang Lv; Jiaxing Wang; Yongjun Luo; Dongdong Jiang; Linwei Li; Zheng Zhou; Wei Zhou; Qingqing Li; Guoyong Yin; Lipeng Yu; Jin Fan; Weihua Cai
Journal:  Aging (Albany NY)       Date:  2019-09-28       Impact factor: 5.682

8.  Engraftment of enteric neural progenitor cells into the injured adult brain.

Authors:  Jaime Belkind-Gerson; Ryo Hotta; Michael Whalen; Naema Nayyar; Nandor Nagy; Lily Cheng; Aaron Zuckerman; Allan M Goldstein; Jorg Dietrich
Journal:  BMC Neurosci       Date:  2016-01-25       Impact factor: 3.288

Review 9.  The Efficacy and Safety of Mesenchymal Stem Cell Transplantation for Spinal Cord Injury Patients: A Meta-Analysis and Systematic Review.

Authors:  Panfeng Xu; Xianliang Yang
Journal:  Cell Transplant       Date:  2018-10-26       Impact factor: 4.064

10.  Topical recombinant human Nerve growth factor (rh-NGF) is neuroprotective to retinal ganglion cells by targeting secondary degeneration.

Authors:  Li Guo; Benjamin M Davis; Nivedita Ravindran; Joana Galvao; Neel Kapoor; Nasrin Haamedi; Ehtesham Shamsher; Vy Luong; Elena Fico; M Francesca Cordeiro
Journal:  Sci Rep       Date:  2020-02-25       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.